Clinical tumor diagnostic markers for BC include Bladder Tumor Antigen (BTA), urine cytology (UroVysion), Urothelial Cancer-Associated Antigen 1 (UCA1), Cytokeratin-19 Fragment (CYFRA 21-1), and Bladder Cancer MCM6 marker [22,23]. Here, MCM6 is linked to urinary bladder carcinoma.